PWMG
DGX icon

Prestige Wealth Management Group’s Quest Diagnostics DGX Stock Holding History

Prestige Wealth Management Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.96K Sell
47
-9
-16% -$1.77K ﹤0.01% 445
2026
Q1 		$11K Hold
56
– – ﹤0.01% 412
2025
Q4 		$9.72K Hold
56
– – ﹤0.01% 447
2025
Q3 		$10.7K Hold
56
– – ﹤0.01% 438
2025
Q2 		$10.1K Hold
56
– – ﹤0.01% 438
2025
Q1 		$9.48K Hold
56
– – ﹤0.01% 449
2024
Q4 		$8.45K Hold
56
– – ﹤0.01% 490
2024
Q3 		$8.69K Hold
56
– – ﹤0.01% 483
2024
Q2 		$7.67K Sell
56
-45
-45% -$6.16K ﹤0.01% 460
2024
Q1 		$13.4K Buy
101
+6
+6% +$778 ﹤0.01% 400
2023
Q4 		$13.1K Buy
95
+25
+36% +$3.29K ﹤0.01% 397
2023
Q3 		$8.53K Sell
70
-48
-41% -$6.39K ﹤0.01% 466
2023
Q2 		$16.6K Buy
118
+19
+19% +$2.62K ﹤0.01% 385
2023
Q1 		$14K Buy
99
+48
+94% +$6.87K ﹤0.01% 382
2022
Q4 		$7.98K Hold
51
– – ﹤0.01% 505
2022
Q3 		$7K Sell
51
-55
-52% -$7.24K ﹤0.01% 479
2022
Q2 		$14K Buy
106
+37
+54% +$5.04K ﹤0.01% 385
2022
Q1 		$10K Buy
69
+17
+33% +$2.37K ﹤0.01% 459
2021
Q4 		$9K Hold
52
– – ﹤0.01% 496
2021
Q3 		$8K Sell
52
-1
-2% -$146 ﹤0.01% 525
2021
Q2 		$7K Hold
53
– – ﹤0.01% 550
2021
Q1 		$7K Sell
53
-80
-60% -$9.86K ﹤0.01% 543
2020
Q4 		$16K Buy
133
+30
+29% +$3.66K ﹤0.01% 382
2020
Q3 		$11K Buy
103
+27
+36% +$3.19K ﹤0.01% 424
2020
Q2 		$8K Sell
76
-1,336
-95% -$142K ﹤0.01% 450
2020
Q1 		$113K Buy
1,412
+1,380
+4,313% +$143K 0.05% 112
2019
Q4 		$3K Buy
32
+18
+129% +$1.88K ﹤0.01% 456
2019
Q3 		$1K Buy
+14
New +$1.44K ﹤0.01% 532
2019
Q1 		– Sell
-42
Closed -$3K – 656
2018
Q4 		$3K Buy
+42
New +$3.94K ﹤0.01% 711

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Prestige Wealth Management Group's DGX Position: Q2 2026 in Review

Prestige Wealth Management Group reduced its Quest Diagnostics (DGX) stake by 16% in Q2 2026, selling an estimated $1.77K and leaving 47 shares worth $9.96K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Prestige Wealth Management Group first reported a position in DGX in Q4 2018 and has held it in 29 quarters since. The position peaked at $113K in Q1 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Prestige Wealth Management Group held 47 shares of Quest Diagnostics worth $9.96K as of Q2 2026.
  • Prestige Wealth Management Group sold 9 Quest Diagnostics shares in Q2 2026, an estimated $1.77K.
  • Quest Diagnostics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #445 holding.
  • Prestige Wealth Management Group first reported a position in Quest Diagnostics in Q4 2018 and has held it in 29 quarters since.
  • Prestige Wealth Management Group's Quest Diagnostics position peaked at $113K in Q1 2020.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.